Hans Biomed (XKRX:042520) Total Stockholders Equity : ₩72,164 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Hans Biomed Total Stockholders Equity?

Hans Biomed's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩72,164 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hans Biomed's Book Value per Share for the quarter that ended in Mar. 2024 was ₩5,556.65. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hans Biomed's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.44.

Hans Biomed Total Stockholders Equity Historical Data

The historical data trend for Hans Biomed's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hans Biomed Total Stockholders Equity Chart

Hans Biomed Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Stockholders Equity

Get a 7-Day Free Trial

74,881.57

60,336.29

44,450.94

45,633.90

49,129.17

Hans Biomed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															58,177.74	57,600.01	49,129.17	72,541.05	72,164.19

Hans Biomed (XKRX:042520) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hans Biomed's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(72164.194	-	0)	/	12.987
	=	5,556.65

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hans Biomed's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(31264.608	+	525.376)	/	72164.194
	=	0.44

Hans Biomed Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hans Biomed's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hans Biomed (XKRX:042520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hans Biomed Corp (XKRX:042520) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

8th Floor SK Building 16-4, Sungsu 1 ga Dong, Sungdong-gu, Seoul, KOR

Website

http://www.hansbiomed.com

Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures artificial skin for a skin graft, various bones mainly for dental implants and joints and medical silicone.

Hans Biomed (XKRX:042520) Headlines

No Headlines